These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32421366)

  • 21. Poor prognosis of nucleophosmin overexpression in solid tumors: a meta-analysis.
    Chen S; He H; Wang Y; Liu L; Liu Y; You H; Dong Y; Lyu J
    BMC Cancer; 2018 Aug; 18(1):838. PubMed ID: 30126359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B7-H3 Overexpression Predicts Poor Survival of Cancer Patients: A Meta-Analysis.
    Ye Z; Zheng Z; Li X; Zhu Y; Zhong Z; Peng L; Wu Y
    Cell Physiol Biochem; 2016; 39(4):1568-80. PubMed ID: 27626927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of TSP-1 as prognostic marker in various cancers: a systematic review and meta-analysis.
    Sun S; Dong H; Yan T; Li J; Liu B; Shao P; Li J; Liang C
    BMC Med Genet; 2020 Jun; 21(1):139. PubMed ID: 32600280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low microRNA-139 expression associates with poor prognosis in patients with tumors: A meta-analysis.
    Chen JA; Yu Y; Xue C; Chen XL; Cui GY; Li J; Li KF; Ren ZG; Sun RR
    Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):321-331. PubMed ID: 30290990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-20a, a novel promising biomarker to predict prognosis in human cancer: a meta-analysis.
    Huang D; Peng Y; Ma K; Deng X; Tang L; Jing D; Shao Z
    BMC Cancer; 2018 Nov; 18(1):1189. PubMed ID: 30497428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
    Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
    Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Prognostic and Clinicopathologic Characteristics of OCT4 and Lung Cancer: A Meta-Analysis.
    Li H; Wang L; Shi S; Xu Y; Dai X; Li H; Wang J; Zhang Q; Wang Y; Sun S; Li Y
    Curr Mol Med; 2019; 19(1):54-75. PubMed ID: 30854966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of chemokine receptor CXCR4 on breast cancer prognosis: a meta-analysis.
    Xu TP; Shen H; Liu LX; Shu YQ
    Cancer Epidemiol; 2013 Oct; 37(5):725-31. PubMed ID: 23763828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of LncRNA GHET1 predicts an unfavourable survival and clinical parameters of patients in various cancers.
    Jiang YF; Zhang HY; Ke J; Shen H; Ou HB; Liu Y
    J Cell Mol Med; 2019 Aug; 23(8):4891-4899. PubMed ID: 31251476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression Data.
    Bozovic-Spasojevic I; Zardavas D; Brohée S; Ameye L; Fumagalli D; Ades F; de Azambuja E; Bareche Y; Piccart M; Paesmans M; Sotiriou C
    Clin Cancer Res; 2017 Jun; 23(11):2702-2712. PubMed ID: 28151718
    [No Abstract]   [Full Text] [Related]  

  • 31. Prognostic and clinicopathological significance of CXCL1 in cancers: a systematic review and meta-analysis.
    Zhang Z; Chen Y; Jiang Y; Luo Y; Zhang H; Zhan Y
    Cancer Biol Ther; 2019; 20(11):1380-1388. PubMed ID: 31387444
    [No Abstract]   [Full Text] [Related]  

  • 32. Prognostic and clinical significance of syndecan-1 expression in breast cancer: A systematic review and meta-analysis.
    Qiao W; Liu H; Guo W; Li P; Deng M
    Eur J Surg Oncol; 2019 Jul; 45(7):1132-1137. PubMed ID: 30598194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Significance of Long Non-coding RNA HULC in Predicting Prognosis and Metastasis of Cancers: a Meta-Analysis.
    Ding Y; Sun C; Li J; Hu L; Li M; Liu J; Pu L; Xiong S
    Pathol Oncol Res; 2019 Jan; 25(1):311-318. PubMed ID: 29110261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the Folate Receptor Proteins FOLR1 and FOLR2 in Correlation With Clinicopathological Variables of Gastric Cancer.
    Anitha S; Ramasamy R; Nachiappa Ganesh R; Dubashi B
    Cureus; 2024 May; 16(5):e61032. PubMed ID: 38915965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated long noncoding RNA MALAT-1 expression is predictive of poor prognosis in patients with breast cancer: a meta-analysis.
    Wang Y; Zhang Y; Hu K; Qiu J; Hu Y; Zhou M; Zhang S
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32700729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic and clinicopathological value of Gli-1 expression in gastric cancer: A meta-analysis.
    Lu L; Wu M; Zhao F; Fu W; Li W; Li X; Liu T
    Oncotarget; 2016 Oct; 7(42):69087-69096. PubMed ID: 27634907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of microRNA-221/222 expression in cancers: evidence from 1,204 subjects.
    Wang J; Liu S; Sun GP; Wang F; Zou YF; Jiao Y; Ning J; Xu J
    Int J Biol Markers; 2014 Jun; 29(2):e129-41. PubMed ID: 24474451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in using folate receptor 1 (FOLR1) for cancer diagnosis and treatment, with an emphasis on cancers that affect women.
    Varaganti P; Buddolla V; Lakshmi BA; Kim YJ
    Life Sci; 2023 Aug; 326():121802. PubMed ID: 37244363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological and prognostic value of CD24 expression in breast cancer: a meta-analysis.
    Liu G; Liu GX; Fang Y; Cao ZY; Du HH; Fu J; Qian K
    Int J Biol Markers; 2017 May; 32(2):e182-e189. PubMed ID: 28315505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cells.
    Huang MJ; Zhang W; Wang Q; Yang ZJ; Liao SB; Li L
    J Ovarian Res; 2018 Feb; 11(1):15. PubMed ID: 29433550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.